Insider Trading - Versant Venture Capital VI L.P.

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Versant Venture Capital VI L.P.
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-03-03
Purchase
2020-03-03
7:03 pm
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
225,000 $18 $4,050,000 4,959,769
(Indirect
Direct)
View
2020-06-23
Purchase
2020-06-25
6:46 pm
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
250,000 $20 $5,000,000 3,419,451
(Indirect)
View
2020-01-02
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
72,444 $19.7 $1,427,272 3,635,113
(Indirect)
View
2020-01-07
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
53,057 $19.99 $1,060,845 2,846,941
(Indirect)
View
2020-08-10
Sale
2020-08-12
7:57 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
13,792 $33.06 $455,989 10,541,469
(Indirect
Direct)
View
2020-10-06
Sale
2020-10-08
7:14 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
45,926 $33.44 $1,535,732 6,056,892
(Indirect
Direct)
View
2020-10-08
Sale
2020-10-13
7:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
22,625 $33.5 $757,924 8,854,094
(Indirect
Direct)
View
2020-10-13
Sale
2020-10-15
7:22 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
17,240 $33.3 $574,015 8,836,854
(Indirect
Direct)
View
2020-10-20
Purchase
2020-10-20
4:58 pm
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
200,000 $15 $3,000,000 3,292,339
(Indirect
Direct)
View
2020-10-15
Sale
2020-10-20
8:09 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,746 $33.44 $526,529 8,821,108
(Indirect
Direct)
View
2020-10-26
Sale
2020-10-28
5:58 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
8,903 $33.28 $296,293 8,812,205
(Indirect
Direct)
View
2020-11-04
Sale
2020-11-06
4:44 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
11,348 $33.14 $376,127 8,800,857
(Indirect
Direct)
View
2020-11-06
Sale
2020-11-10
7:24 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
9,400 $33.08 $310,949 8,791,457
(Indirect
Direct)
View
2020-11-10
Sale
2020-11-12
5:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
39,583 $34.11 $1,350,354 8,751,874
(Indirect
Direct)
View
2020-11-11
Sale
2020-11-13
7:47 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,598 $34.15 $532,642 6,937,033
(Indirect
Direct)
View
2020-11-13
Sale
2020-11-17
7:33 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,700 $33.74 $158,587 7,781,576
(Indirect
Direct)
View
2020-11-17
Sale
2020-11-19
9:19 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,730 $33.05 $156,349 7,776,846
(Indirect
Direct)
View
2020-11-19
Sale
2020-11-23
4:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
130,017 $33.01 $4,291,861 7,646,829
(Indirect
Direct)
View
2020-11-27
Sale
2020-12-01
7:13 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
10,393 $33.15 $344,513 6,062,813
(Indirect
Direct)
View
2021-06-22
Purchase
2021-06-23
4:30 pm
Century Therapeutics Inc. IPSC Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage II L.P.
Versant Vantage II GP L.P.
Versant Vantage II GP-GP LLC
10% Owner
100,000 $20 $2,000,000 13,630,909
(Indirect
Direct)
View
2021-06-28
Purchase
2021-06-30
5:00 pm
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
157,895 $19 $3,000,005 8,897,053
(Indirect
Direct)
View
2021-06-29
Purchase
2021-07-01
7:01 pm
Graphite Bio Inc. GRPH Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage II L.P.
Versant Vantage II GP L.P.
Versant Vantage II GP-GP LLC
10% Owner
180,000 $17 $3,060,000 16,416,117
(Indirect
Direct)
View
2021-10-18
Sale
2021-10-20
4:38 pm
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
550,000 $14.84 $8,160,736 3,245,533
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
4,734,769 $0 4,959,769
(Direct)
View
2020-06-23
Conversion
2020-06-25
6:46 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
6,245,349 $0 3,419,451
(Indirect)
View
2020-01-02(A)
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
709,629 $0 3,635,113
(Indirect)
View
2020-07-21
Conversion
2020-07-21
7:41 pm
N/A
N/A
Pandion Therapeutics Inc. PAND Versant Venture Capital VI L.P.
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
21,530,967 $0 3,754,051
(Direct)
View
2020-07-27
Other
2020-07-29
9:56 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
339,843 $0 7,151,621
(Indirect)
View
2020-08-12
Other
2020-08-14
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
311,176 $0 10,563,821
(Direct)
View
2020-08-18
Other
2020-08-20
6:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
311,176 $0 10,263,821
(Direct)
View
2020-09-17
Other
2020-09-21
7:28 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
754,743 $0 6,569,238
(Direct)
View
2020-10-06
Other
2020-10-08
7:14 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
299,051 $0 6,056,892
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
3,092,339 $0 3,292,339
(Direct)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
984,298 $0 6,937,033
(Direct)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
788,828 $0 5,151,052
(Direct)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
440,782 $0 6,062,813
(Direct)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
21,401 $0 5,628,442
(Indirect)
View
2020-12-15
Other
2020-12-17
9:03 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
325,000 $0 4,545,416
(Indirect)
View
2021-01-14
Other
2021-01-19
8:16 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
583,680 $0 596,808
(Indirect)
View
2021-01-29
Other
2021-02-02
6:54 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
736,081 $0 751,218
(Indirect)
View
2021-02-16
Other
2021-02-18
5:09 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
362,672 $0 2,785,290
(Indirect)
View
2021-02-17
Other
2021-02-19
5:16 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
337,107 $0 5,604,496
(Direct)
View
2021-03-26
Other
2021-03-30
7:05 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
404,849 $0 3,738,334
(Indirect)
View
2021-05-05
Other
2021-05-07
4:38 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
341,275 $0 3,397,481
(Indirect)
View
2021-05-12
Other
2021-05-14
4:45 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
404,844 $0 3,736,306
(Indirect)
View
2021-06-01
Other
2021-06-03
4:31 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
77,247 $0 4,843,145
(Indirect)
View
2021-06-22
Conversion
2021-06-23
4:30 pm
N/A
N/A
Century Therapeutics Inc. IPSC Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage II L.P.
Versant Vantage II GP L.P.
Versant Vantage II GP-GP LLC
10% Owner
37,095,231 $0 13,630,909
(Direct)
View
2021-06-28
Conversion
2021-06-30
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
38,309,520 $0 8,897,053
(Direct)
View
2021-06-29
Conversion
2021-07-01
7:01 pm
N/A
N/A
Graphite Bio Inc. GRPH Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage II L.P.
Versant Vantage II GP L.P.
Versant Vantage II GP-GP LLC
10% Owner
47,606,806 $0 16,416,117
(Direct)
View
2021-08-05
Other
2021-08-09
4:44 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
156,610 $0 4,924,800
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next